A systems-based method to repurpose marketed therapeutics for antiviral use: a SARS-CoV-2 case study
Mengran Wang, Susan Dina Ghiassian(Boston Engineering (United States)), Michael O. McAnally, Johanna B. Withers(BG Medicine (United States)), Helia N. Sanchez(BG Medicine (United States)), Viatcheslav R. Akmaev, Ivan Voitalov, Alif Saleh(BG Medicine (United States)), Piero Ricchiuto(Brigham and Women's Hospital)
Cited by 4
Related Papers
A Proteome-Scale Map of the Human Interactome Network
|Cell|2014|1.5k
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
|PubMed Central|2020|528
A DIseAse MOdule Detection (DIAMOnD) Algorithm Derived from a Systematic Analysis of Connectivity Patterns of Disease Proteins in the Human Interactome
|PLoS Computational Biology|2015|406
The human sex ratio from conception to birth
|Proceedings of the National Academy of Sciences|2015|287